|The inaugural Australia Biotech Invest conference was a great success!
Australia’s largest life science deal-making event, which AusBiotech and Beacon Events organised on 28-29 October in Melbourne, welcomed over 300 senior level delegates from the life science community. More than 47% of the audience consisted of qualified investors who came to discover and hand-pick promising biotech investment opportunities.
Over the two days, a line-up of 33 pioneering biotech companies presented their pipelines and investment cases to the attentive investor audience and 142 business meetings were set up through the online BioInvest Partnering system to further discuss investment or partnership opportunities.
Delegates also benefited from panel discussions and keynotes by leading international investors, industry advisors and big pharma representatives on such topics as: Trends in global and regional biotech investment; partnering strategies and successful biotech business models; doing business with and accessing investment out of China; smart ways to create value from spins-outs; and key challenges and opportunities for the biotech sector in the years to come.
Australia Biotech Invest 2013 received extensive media coverage:
New guide launched at major life science investor event
Renaissance for Australia’s biotech industry
Aus minister launches code book for directors
Nexvet Raises $7 Million from International Investor Syndicate in Oversubscribed Capital Raise
Event Photo Gallery
|Take part in our post-event survey
Presenting Company Survey